Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMBRISENTAN vs AMIFOSTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMBRISENTAN vs AMIFOSTINE: Safety Overview

Metric AMBRISENTAN AMIFOSTINE
Total FAERS Reports 86,197 125
Deaths Reported 10,291 7
Death Rate 11.9% 5.6%
Hospitalizations 32,910 35
Average Patient Age 59.5 yrs 53.3 yrs
% Female Patients 76.1% 45.4%
FDA Approval Date Apr 10, 2019 Dec 8, 1995
Manufacturer Sigmapharm Laboratories, LLC N/A
Route ORAL N/A
Marketing Status Prescription Discontinued